Physician profile
Adra Jaehnig
NPI 1992514145
$612.92
in general payments reported to CMS, 2019-2025
7 companies · $613 in 2025
The $613 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $285.48 | 2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $158.17 | 2025 | Ha Minuteman G3-R |
| Protega Pharmaceutials INC | $90.41 | 2025 | Roxybond |
| Boston Scientific Corporation | $25.29 | 2025 | Intracept |
| Abbott Laboratories | $21.09 | 2025 | Proclaim |
| Valinor Pharma, LLC | $18.96 | 2025 | Movantik |
| Collegium Pharmaceutical, INC. | $13.52 | 2025 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adra Jaehnig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.